Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy

被引:5
作者
Frankenstein, Lutz [1 ]
Hees, Henrik [1 ]
Taeger, Tobias [1 ]
Froehlich, Hanna [1 ]
Doesch, Andreas [1 ]
Cebola, Rita [1 ]
Zugck, Christian [1 ]
Katus, Hugo A. [1 ]
机构
[1] Heidelberg Univ, Dept Cardiol, D-69120 Heidelberg, Germany
关键词
Chronic heart failure; Dilated cardiomyopathy; Coronary artery disease; Survival; Phenotype; CHRONIC HEART-FAILURE; MARTINGALE-BASED RESIDUALS; EUROPEAN-SOCIETY; TASK-FORCE; ISCHEMIC CARDIOMYOPATHY; OF-CARDIOLOGY; DIAGNOSIS; ASSOCIATION; GUIDELINES; SURVIVAL;
D O I
10.1007/s00392-013-0589-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with idiopathic dilated cardiomyopathy (dCMP) might present coronary artery disease (CAD) concomitant to dCMP and prognostic differences between ischemic heart disease and non-ischemic cardiomyopathy have been described. Clinical characteristics and prognostic implications of concomitant CAD in patients with dCMP are largely unknown. A total of 1,263 patients with chronic systolic dysfunction from dCMP-of these 67.1 % (n = 847; 72.3 % men) without and 32.9 % (n = 416; 80.8 % men) with concomitant CAD were included and baseline clinical characteristics noted. They were followed prospectively for 36.3 (20.8-65.0) months, representing 5,168 patient-years. All-cause mortality was the primary endpoint; and decompensation requiring hospitalisation as well as the combined endpoint thereof were secondary endpoints. Independent significant predictors of CAD were smoking status (current smoker: OR 2.68, 95 % CI 1.61-4.46; p < 0.001; past smoker: OR 2.52, 95 % CI 1.40-4.52; p < 0.005; each vs. non-smoker), presence of dyslipidemia (OR 3.46, 95 % CI 2.23-5.35; p < 0.001), age (OR 1.06, 95 % CI 1.04-1.08; p < 0.001), and female sex (OR 0.49, 95 % CI 0.29-0.81; p = 0.005). The presence of CAD was not a significant predictor of all-cause mortality (adjusted HR 0.74, 95 % CI 0.36-1.54; p = 0.42), morbidity (adjusted HR 1.48, 95 % CI 0.55-3.99; p = 0.44), or the combined endpoint (HR 0.65, 95 % CI 0.24-1.78; p = 0.40). Concomitant CAD is common in patients with dCMP. Clinical predictors of its presence are largely coincident with classic risk factors in the general population. The presence of concomitant CAD appears not to be associated with adverse prognosis (morbidity or mortality) in patients with dCMP.
引用
收藏
页码:771 / 780
页数:10
相关论文
共 36 条
[1]   Relation between gender, etiology and survival in patients with symptomatic heart failure [J].
Adams, KF ;
Dunlap, SH ;
Sueta, CA ;
Clarke, SW ;
Patterson, JH ;
Blauwet, MB ;
Jensen, LR ;
Tomasko, L ;
Koch, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (07) :1781-1788
[2]   Coronary reserve impairment prevents the improvement of left ventricular dysfunction and adversely affects the long-term outcome of patients with hypertensive dilated cardiomyopathy [J].
Angelim Pereira, Valeria Fontenelle ;
Frimm, Clovis de Carvalho ;
Tudi Rodrigues, Ana Clara ;
Statistician, Mariana Curi .
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2010, 4 (01) :14-21
[3]   Discordance between pre and post cardiac transplant diagnosis: Implications for pre- and postoperative decision making [J].
Angelini, A ;
Boffa, GM ;
Livi, U ;
Barchitta, A ;
Casarotto, D ;
Thiene, G .
CARDIOVASCULAR PATHOLOGY, 1999, 8 (01) :17-23
[4]   Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy [J].
Bart, BA ;
Shaw, LK ;
McCants, CB ;
Fortin, DF ;
Lee, KL ;
Califf, RM ;
OConnor, CM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (04) :1002-1008
[5]   DISCREPANCY BETWEEN PRETRANSPLANT AND POSTTRANSPLANT DIAGNOSIS OF END-STAGE DILATED CARDIOMYOPATHY [J].
BORTMAN, G ;
SELLANES, M ;
ODELL, DS ;
RING, WS ;
OLIVARI, MT .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (09) :921-924
[6]  
Chang A, LTD STP SAMPLE SIZE
[7]   Cardiovascular critical event pathways for the progression of heart failure -: A report from the ATLAS study [J].
Cleland, JGF ;
Thygesen, K ;
Uretsky, BF ;
Armstrong, P ;
Horowitz, JD ;
Massie, B ;
Packer, M ;
Poole-Wilson, PA ;
Rydén, L .
EUROPEAN HEART JOURNAL, 2001, 22 (17) :1601-1612
[8]   Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients [J].
Cooke, GE ;
Eaton, GM ;
Whitby, G ;
Kennedy, RA ;
Binkley, PF ;
Moeschberger, ML ;
Leier, CV .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (02) :509-516
[9]   No gender survival difference in a population of patients with chronic heart failure related to left ventricular systolic dysfunction and receiving optimal medical therapy [J].
de Groote, P. ;
Lamblin, N. ;
Mouquet, F. ;
Bauters, C. .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2008, 101 (04) :242-248
[10]   Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy [J].
de Jong, Richard M. ;
Tio, Rene A. ;
van der Harst, Pim ;
Voors, Adriaan A. ;
Koning, Paul M. ;
Zeebregts, Clark J. A. M. ;
van Veldhuisen, Dirk J. ;
Dierckx, Rudi A. J. O. ;
Slart, Riemer H. J. A. .
JOURNAL OF NUCLEAR CARDIOLOGY, 2009, 16 (05) :769-774